BRUSSELS: The European Commission has launched legal proceedings against Anglo-Swedish drugmaker AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines, and for not having a "reliable" plan to ensure timely deliveries.
A first hearing in the case will be held at the Brussels Court of First Instance from 9 a.m. (0700 GMT) on Wednesday.
The proceedings will be public and conducted under an emergency procedure, which means they could be concluded in a matter of weeks, the European Union's executive Commission said.
HOW DID IT COME TO THIS?
The EU's decision to sue AstraZeneca came after the company repeatedly cut supplies to the 27-nation bloc, contributing to major delays in Europe's vaccine rollout, which has lagged those in Britain and the United States.
Under the contract, which was drawn up under Belgian law, the company committed to making its "best reasonable efforts" to deliver 300 million vaccine doses from December 2020 to June 2021, including 180 million in the current second quarter.
However, the company said in a statement on March 12 that it would aim to deliver only one-third of that 300 million total, of which about 70 million would be in the second quarter.
A week later, Brussels sent a legal letter to AstraZeneca, in the first step of potential court proceedings.
WHAT DOES ASTRAZENECA SAY?
AstraZeneca says the EU's legal action is without merit, argues that it complied with the contract, and has pledged to defend itself robustly in court.
WHAT'S IN IT FOR THE EU?
EU officials say the aim of the lawsuit is to compel AstraZeneca to deliver more vaccines than the number it has said it would aim to deliver.
The EU wants as many as possible of the promised 300 million doses, but would settle for 130 million by the end of June, an EU source familiar with the discussions told Reuters.
Brussels will also want AstraZeneca to explain to the court how it spent more than 224 million euros ($270 million) granted by the EU last September to buy vaccine ingredients, and for which the bloc said the company did not provide sufficient documents confirming the purchases.
If successful in court, the EU would send a warning to other vaccine suppliers. Pharmaceutical Johnson & Johnson has warned the EU it may not deliver the 55 million doses of its COVID-19 vaccine that it contracted to supply in the second quarter.
WHAT ARE THE RISKS FOR THE EU?
Some member states were initially reluctant to sue AstraZeneca on the grounds that it would take too long and, rather than speed up deliveries, only exacerbate tensions with a company they are still counting on for their vaccine campaigns.
If the EU loses its case in the Brussels court, it would be a public relations blow on top of criticism over its handling of vaccine purchase agreements and rollout of shots.
HOW FAR IS THE EU STILL RELYING ON ASTRAZENECA?
The AstraZeneca shot developed by Oxford University was supposed to be the main one in the EU vaccination campaign for the first half of this year.
However, the EU has now distanced itself from the company due to the supply problems and concerns over the efficacy and safety of the vaccine.
The bloc has forgone another 100 million AstraZeneca shots that it had an option to buy under the contract signed last August, and is now relying mostly on the Pfizer-BioNTech vaccine to inoculate at least 70% of EU adults by the end of July.
Still, while the AstraZeneca shot has been linked to very rare cases of blood clots, the EU drug regulator has recommended its use to contain the spread of COVID-19.
Reuters
Wed Apr 28 2021
![How the EU and AstraZeneca ended up in court, and what next How the EU and AstraZeneca ended up in court, and what next](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-04/41618469405_TBAstraZeneca.jpg)
The EU's decision to sue AstraZeneca came after the company repeatedly cut supplies to the 27-nation bloc, contributing to major delays in Europe's vaccine rollout, which has lagged those in Britain and the United States. REUTERSpic
![Polis serbu 10 premis urut tawar khidmat seks, tahan 39 wanita warga asing Polis serbu 10 premis urut tawar khidmat seks, tahan 39 wanita warga asing](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81720349985_TBmassage.jpg)
Polis serbu 10 premis urut tawar khidmat seks, tahan 39 wanita warga asing
Polis menahan 39 wanita warga asing yang disyaki bekerja sebagai pekerja seks dan tukang urut dalam serbuan di 10 premis urut sekitar Lembah Klang, Jumaat lepas.
PDRM kutip lebih RM1 juta diskaun saman
Ketua Jabatan Siasatan dan Penguatkuasaan Trafik Kontinjen Pahang Deputi superintanden Ahmad Ridha Hariri berkata jumlah itu ialah hasil bayaran yang diterima daripada 2,000 pengunjung yang mendapatkan tawaran diskaun 50 peratus daripada PDRM.
AWANI Ringkas: Tuntutan RM100 juta tidak berasas
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
AWANI Borneo [07/07/2024] - Tiada kemalangan jiwa | PRN Sabah | Maal Hijrah 2024
Awani Borneo 7 Julai 2024 bersama Jasmine Abu Bakar;
1. Dua rumah musnah dalam kebakaran di Kundasang
2. Sabah tidak perlu parti luar, perkukuh blok Borneo - Shadie Apdal
3. Yang di-Pertuan Agong gesa kerajaan tingkat kuatkuasa kandungan ajaran sesat
1. Dua rumah musnah dalam kebakaran di Kundasang
2. Sabah tidak perlu parti luar, perkukuh blok Borneo - Shadie Apdal
3. Yang di-Pertuan Agong gesa kerajaan tingkat kuatkuasa kandungan ajaran sesat
![Exists, Ungu ‘berentap’ di pentas konsert pada 14 Julai ini Exists, Ungu ‘berentap’ di pentas konsert pada 14 Julai ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81720350574_ExistsUngu.jpg)
Exists, Ungu ‘berentap’ di pentas konsert pada 14 Julai ini
Bakal berlangsung selama 3 jam setengah ini, konsert ini akan dipenuhi dengan lagu-lagu hit daripada dua buah kumpulan ini.
Urus tadbir perlu bersifat telus, ambil kira cabaran rakyat
Premier Sarawak, Tan Sri Abang Johari Tun Openg mahu urus tadbir wilayah itu sentiasa mengambil kira cabaran yang dihadapi oleh manusia sejagat.
Pendekatan agresif noktahkan miskin tegar di Sabah
Kerajaan Negeri Sabah terus mengambil pendekatan bersifat agresif bagi menoktahkan isu miskin tegar di Sabah.
Graduan Iban pertama Universiti Al-Azhar penerima Anugerah Ma’al Hijrah Sarawak 1446H
Graduan Iban pertama yang melanjutkan pengajian ke Universiti Al-Azhar di Kaherah, Mesir antara 14 penerima yang menerima Anugerah Ma’al Hijrah Sarawak pada Majlis Perhimpunan Ma’al Hijrah Peringkat Sarawak Tahun 1446H/2024M di Hikmah Exchange Event Centre, Kuching hari ini.
![Remaja Asia: Khai Xing-Aaron gagal akhiri kemarau tujuh tahun Malaysia Remaja Asia: Khai Xing-Aaron gagal akhiri kemarau tujuh tahun Malaysia](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51720347946_Badminton.jpg)
Remaja Asia: Khai Xing-Aaron gagal akhiri kemarau tujuh tahun Malaysia
Beregu lelaki negara Kang Khai Xing-Aaron Tai gagal mengakhiri kemarau kejuaraan selama tujuh tahun Malaysia di Kejohanan Badminton Remaja Asia.
Sabah tidak perlu parti luar, perkukuh blok Borneo - Shafie
Presiden Parti Warisan, Datuk Seri Shafie Apdal memberitahu parti berasal dari Sarawak tidak perlu memasuki Sabah untuk mengukuhkan kerjasama blok borneo.
![‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’ ‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-03/71647054545_DatukDrNoorHisham.jpg)
‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’
Golongan berisiko tinggi adalah individu yang mempunyai sejarah pembekuan darah dan mereka tidak dibenarkan menerima vaksin jenis AZ.
![KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/51714998751_Dzulkefly.jpg)
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-03/71709993909_TBBERITAx.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/51632498837_TBCOVIDVACCINE.jpg)
AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan
Vaksin itu tidak lagi boleh digunakan di EU selepas syarikat itu secara sukarela menarik balik "kebenaran pemasarannya."
![KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/51714998751_Dzulkefly.jpg)
KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly
KKM memberi jaminan akan mendedahkan semua data berhubung kesan sampingan susulan imunisasi (AEFI) yang berpunca daripada vaksin COVID-19 pada satu waktu yang akan ditetapkan.
![Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/51632498837_TBCOVIDVACCINE.jpg)
Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya
Suruhanjaya Nasional untuk Kajian dan Pencegahan Peristiwa Mudarat Berikutan Imunisasi dan BPOM melakukan pemantauan bagi membuat rumusan.
![Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-05/81714645375_AstraZeneca.jpg)
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
![AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19 AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-07/71690377692_gaveltukulmahkam.jpg)
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
![AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-10/71697864703_mySihatPal.jpg)
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
![AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-09/71632796213_AstraZenecasthera.jpg)
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.